Healthline
September 23, 2025
Share on PinterestThe FDA will advise physicians about the potential risks of Tylenol during pregnancy. Getty Images The Trump administration said the FDA will begin notifying […]
September 20, 2025
Share on PinterestTwo new studies found that higher doses of semaglutide safely led to greater weight loss with minimal side effects. Olena Malik/Getty Images Researchers say […]
September 19, 2025
Share on PinterestExperts say everyone who is eligible should get vaccinated against influenza this fall. Getty Images/Maskot Health officials anticipate this winter’s flu season to be […]
September 18, 2025
Share on PinterestMore than half of heart attacks in younger females could stem from causes other than artery blockage. Tashdique Mehtaj Ahmed/Getty Images Doctors often assume […]
Medscape
July 3, 2025
TOPLINE: In a network meta-analysis of 25 randomized trials, sonelokimab was ranked highest for treating patients with moderate-to-severe hidradenitis suppurativa (HS). Adalimumab, lutikizumab, and bimekizumab were […]
July 2, 2025
The FDA has granted accelerated approval to linvoseltamab (Lynozyfic, Regeneron) for relapsed or refractory multiple myeloma (MM) after at least four prior lines of therapy, including […]
July 2, 2025
The number of live births in England and Wales rose last year, the first increase since 2021, according to the Office for National Statistics (ONS). There were […]
July 2, 2025
For nearly 15 years, Donald Edmondson, PhD, executive director of the Center for Behavioral Cardiovascular Health at Columbia University Irving Medical Center in New York City, […]
FDA
November 10, 2025
Product: Drugs Recipient: Recipient Name Konrad Rejdak, M.D. Konrad Rejdak, MD, PhD Samodzielny Publiczny SzpitalKliniczny Nr 4 w Lublinie, ul. Jaczewskiego 8,20-090 LublinPoland [email protected] Issuing Office: […]
November 7, 2025
Summary Company Announcement Date: November 06, 2025 FDA Publish Date: November 07, 2025 Product Type: Drugs Reason for Announcement: Recall Reason Description Out-of-specification endotoxin results Company […]
November 6, 2025
On November 6, 2025, the Food and Drug Administration approved daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) for adults with high-risk smoldering multiple myeloma (SMM). […]
November 6, 2025
Docket Number: FDA-2017-D-0040 Issued by: Guidance Issuing Office Office of the Commissioner, Office of the Chief Medical Officer, Office of Combination Products This guidance is intended […]
